Use of ghostwriters, guest authors appears frequent for studies involving rofecoxib
A study found that company employees and unacknowledged authors often wrote clinical trial articles and review papers on rofecoxib, while primary authors had little to do with the research. Guest authorship was common in review articles, but ghostwriting was also prevalent.